# The Panther Opportunity Fund

> The Panther Opportunity Fund is a VC fund in Chicago backing Cannabis and Health Care. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Chicago, United States
- Total investments: 4
- Last investment: Oct 2020
- Lead investor: 25%
- Last updated: Aug 2026

The Panther Opportunity Fund is a VC fund in Chicago focused on Cannabis and Health Care. The Panther Opportunity Fund

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Cannabis | 3 | 75% |
| Health Care | 2 | 50% |
| Medical | 1 | 25% |
| Software | 1 | 25% |
| Wholesale | 1 | 25% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series A | 1 | 25% |
| Series B | 1 | 25% |
| Convertible Note | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| The Blinc Group | Headquartered in New York City, The Blinc Group designs, develops, supplies and supports premium cannabis vaping hardware. The company offers a curated collection of proven cartridges, batteries, ready to use vaporizers and complete bespoke device development to multi-state operators, licensed producers, processors and brands. Blinc completes thevalue chain by providing its clients access to a suite of support services ranging from research and development, production, testing, standard operating procedures, training and all the way to go-to-market strategy and brand communications consulting. With full control of the supply chain, the company’s unique “Powered by Blinc” process enables clients to provide innovative, safe and quality controlled products to cannabis consumers worldwide. To learn more about Blinc, visit http://www.theblincgroup.com. |  | Convertible Note | Oct 30, 2020 | http://www.theblincgroup.com |
| Apex Trading | Apex Trading is the cannabis industry's premier enterprise wholesale platform. The company was founded in 2018 by three industry veterans with the mission of providing the industry with tools that increase profits, improve the daily lives of staff, and create greater connectivity between producers and their retail customers. Apex Tradingequips cannabis producers with tools that streamline their entire wholesale process and empower sales and marketing teams through industry-tailored features like inventory & order management, tasking, CRM, email marketing, and custom storefront solutions. Since launching in 2018, Apex Trading has scaled into 18 state markets and has facilitated more than 200,000 transactions between 500+ brands and 2,500+ retailers. | $1.7M | Seed | Oct 17, 2019 | http://www.apextrading.com/ |
| PathogenDx | PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $7.5M | Series B | Sep 30, 2019 | http://www.pathogendx.com/ |
| PathogenDx | PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. |  | Series A |  | http://www.pathogendx.com/ |

4 of 4 investments shown.

## Co-investors
- [Altitude Investment Management](https://shizune.co/investors/profile/altitude-investment-management) — VC Fund, 3 deals together
- [7thirty Capital](https://shizune.co/investors/profile/7thirty-opportunity-fund) — VC Fund, 2 deals together
- [Arcadian Investment Partners](https://shizune.co/investors/profile/arcadian-investment-partners) — VC Fund, 1 deal together
- [Arcview Collective Fund](https://shizune.co/investors/profile/arcview-collective-fund) — VC Fund, 1 deal together
- Canopy Ventures — VC Fund, 1 deal together
- [Cresco Capital Partners](https://shizune.co/investors/profile/cresco-capital-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does The Panther Opportunity Fund invest in?

The Panther Opportunity Fund invests primarily in Cannabis, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did The Panther Opportunity Fund last invest?

The most recent investment recorded for The Panther Opportunity Fund closed in Oct 2020. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co